SuperNova Dx, KSB Partner on Inflammatory Marker Test | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – SuperNova Diagnostics today said that it will collaborate with Shenzhen Kang Bao Bio-Technology (KSB) on developing and commercializing diagnostics and services for the measurement of the analyte neopterin.

The firms plan to develop the products and services using SuperNova's AmpCrystal technology and offer them in China and affiliated markets. Financial and further details of the collaboration were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.